Results 111 to 120 of about 2,572,587 (193)

Continuous subcutaneous insulin infusion alters microRNA expression and glycaemic variability in children with type 1 diabetes. [PDF]

Sci Rep, 2021
Scott ES, Januszewski AS, Carroll LM, Fulcher GR, Joglekar MV, Hardikar AA, Jones TW, Davis EA, Jenkins AJ.   +8 more
europepmc   +1 more source

Ultra-Rapid Lispro Has an Improved Pharmacokinetic Profile for Exercise Compared With Lispro, Resulting in Less Exercise-Associated Hypoglycemia in Adults With Type 1 Diabetes on Open-Loop Continuous Subcutaneous Insulin Infusion. [PDF]

Diabetes Care
Leohr JK, Abitbol A, Turner LV, Smith LaBell E, Ghosh A, Coutant DE, Riddell MC.   +6 more
europepmc   +1 more source

Effects of continuous subcutaneous insulin infusion on the microstructures, mechanical properties and bone mineral compositions of lumbar spines in type 2 diabetic rats. [PDF]

BMC Musculoskelet Disord, 2022
Hu X, Gong H, Hou A, Wu X, Shi P, Zhang Y.   +5 more
europepmc   +1 more source

Factors influencing insulin requirements in using continuous subcutaneous insulin infusion or multiple daily injections in type 2 diabetes. [PDF]

World J Diabetes
Sun RM, Dai DX, Xu F, Ling YL, Xie ZJ.
europepmc   +1 more source

Outcomes for continuous subcutaneous insulin infusion users in young adults from lower socioeconomic backgrounds. [PDF]

Endocrinol Diabetes Metab, 2021
McKee AM, Albert SG, Al-Hammadi N, Hinyard LJ.   +3 more
europepmc   +1 more source

Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections for Glycemic Control in Pediatric Patients With Type 1 Diabetes Mellitus: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis. [PDF]

AACE Endocrinol Diabetes
Calderon Martinez E, Saji SZ, Sámano Sánchez M, Nieto M, Hammoud A, De la Rosa-Valdez E, Briceno Silva G, Arruarana VS, Newman Molina A, Sanchez Cruz C, Noreña JA, Correa Marquez R.   +11 more
europepmc   +1 more source

Impact of tailored diabetes education on adherence and glycemic control in children and adolescents on continuous subcutaneous insulin infusion, prospective interventional study in a tertiary center. [PDF]

BMC Pediatr
Hassan M, ElHelaly M, Badawi N, Nader M, Shamma R.   +4 more
europepmc   +1 more source

Lost in Translation: A Disconnect Between the Science and Medicare Coverage Criteria for Continuous Subcutaneous Insulin Infusion. [PDF]

Diabetes Technol Ther, 2021
Aleppo G, Parkin CG, Carlson AL, Galindo RJ, Kruger DF, Levy CJ, Umpierrez GE, Forlenza GP, McGill JB.   +8 more
europepmc   +1 more source

Successful Treatment of a Very Low-Birth-Weight Infant With GATA6 Neonatal Diabetes Using Continuous Subcutaneous Insulin Infusion. [PDF]

Cureus
Ito T, Suzuki A, Yamaguchi N, Aoyama K, Negishi Y, Tanaka H, Yorifuji T, Ishida A.   +7 more
europepmc   +1 more source

Continuous Subcutaneous Insulin Infusion (CSII) Combined with Oral Glucose-Lowering Drugs in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis of Randomized, Controlled Trials. [PDF]

Pharmaceuticals (Basel), 2022
Li H, Yang A, Zhao S, Chow EY, Javanbakht M, Li Y, Lin D, Xu L, Zang D, Wang K, Ma L.   +10 more
europepmc   +1 more source